-
1
-
-
28344453595
-
-
IARC Press, Lyon, W.D. Travis, E. Brambilla, H.K. Muller-Hermelink, C.C. Harris (Eds.)
-
Tumours of the lung, pleura, thymus and heart. Pathology and genetics. WHO classification of tumours 2004, IARC Press, Lyon. W.D. Travis, E. Brambilla, H.K. Muller-Hermelink, C.C. Harris (Eds.).
-
(2004)
Tumours of the lung, pleura, thymus and heart. Pathology and genetics. WHO classification of tumours
-
-
-
2
-
-
0041329952
-
Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan
-
Kondo K., Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003, 76:878-884.
-
(2003)
Ann Thorac Surg
, vol.76
, pp. 878-884
-
-
Kondo, K.1
Monden, Y.2
-
3
-
-
79961058814
-
Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer
-
Furugen M., Sekine I., Tsuta K., Horinouchi H., Nokihara H., Yamamoto N., et al. Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer. Jpn J Clin Oncol 2011, 41:1013-1016.
-
(2011)
Jpn J Clin Oncol
, vol.41
, pp. 1013-1016
-
-
Furugen, M.1
Sekine, I.2
Tsuta, K.3
Horinouchi, H.4
Nokihara, H.5
Yamamoto, N.6
-
4
-
-
77953164902
-
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience
-
Grassin F., Paleiron N., André M., Caliandro R., Bretel J.J., Terrier P., et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience. J Thorac Oncol 2010, 5:893-897.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 893-897
-
-
Grassin, F.1
Paleiron, N.2
André, M.3
Caliandro, R.4
Bretel, J.J.5
Terrier, P.6
-
5
-
-
77956259167
-
Insulin-like growth factor-1 receptor expression in thymic malignancies
-
Girard N., Teruya-Feldstein J., Payabyab E.C., Riely G.J., Rusch V.W., Kris M.G., et al. Insulin-like growth factor-1 receptor expression in thymic malignancies. J Thorac Oncol 2010, 5:1439-1446.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 1439-1446
-
-
Girard, N.1
Teruya-Feldstein, J.2
Payabyab, E.C.3
Riely, G.J.4
Rusch, V.W.5
Kris, M.G.6
-
6
-
-
77957583341
-
Thymoma and thymic carcinoma: molecular pathology and targeted therapy
-
Ströbel P., Hohenberger P., Marx A. Thymoma and thymic carcinoma: molecular pathology and targeted therapy. J Thorac Oncol 2010, 5:S286-S290.
-
(2010)
J Thorac Oncol
, vol.5
-
-
Ströbel, P.1
Hohenberger, P.2
Marx, A.3
-
7
-
-
72549108625
-
Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas
-
Girard N., Shen R., Guo T., Zakowski M.F., Heguy A., Riely G.J., et al. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res 2009, 15:6790-6799.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 6790-6799
-
-
Girard, N.1
Shen, R.2
Guo, T.3
Zakowski, M.F.4
Heguy, A.5
Riely, G.J.6
-
8
-
-
33846682699
-
Topoisomerase 2alpha plays a pivotal role in the tumor biology of stage IV thymic neoplasia
-
Liu J.M., Wang L.S., Huang M.H., Hsu W.H., Yen S.H., Shiau C.Y., et al. Topoisomerase 2alpha plays a pivotal role in the tumor biology of stage IV thymic neoplasia. Cancer 2007, 109:502-509.
-
(2007)
Cancer
, vol.109
, pp. 502-509
-
-
Liu, J.M.1
Wang, L.S.2
Huang, M.H.3
Hsu, W.H.4
Yen, S.H.5
Shiau, C.Y.6
-
9
-
-
0037288975
-
Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in thymoma
-
Sasaki H., Fukai I., Kiriyama M., Kaji M., Yano M., Yamakawa Y., et al. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in thymoma. Surg Today 2003, 33:83-88.
-
(2003)
Surg Today
, vol.33
, pp. 83-88
-
-
Sasaki, H.1
Fukai, I.2
Kiriyama, M.3
Kaji, M.4
Yano, M.5
Yamakawa, Y.6
-
10
-
-
33749587054
-
Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase
-
Ceppi P., Volante M., Saviozzi S., Rapa I., Novello S., Cambieri A., et al. Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase. Cancer 2006, 107:1589-1596.
-
(2006)
Cancer
, vol.107
, pp. 1589-1596
-
-
Ceppi, P.1
Volante, M.2
Saviozzi, S.3
Rapa, I.4
Novello, S.5
Cambieri, A.6
-
11
-
-
33845361135
-
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
-
Ceppi P., Volante M., Novello S., Rapa I., Danenberg K.D., Danenberg P.V., et al. ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. Ann Oncol 2006, 17:1818-1825.
-
(2006)
Ann Oncol
, vol.17
, pp. 1818-1825
-
-
Ceppi, P.1
Volante, M.2
Novello, S.3
Rapa, I.4
Danenberg, K.D.5
Danenberg, P.V.6
-
12
-
-
33748435058
-
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
-
Olaussen K.A., Dunant A., Fouret P., Brambilla E., André F., Haddad V., et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006, 355:983-991.
-
(2006)
N Engl J Med
, vol.355
, pp. 983-991
-
-
Olaussen, K.A.1
Dunant, A.2
Fouret, P.3
Brambilla, E.4
André, F.5
Haddad, V.6
-
13
-
-
0029848361
-
Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases
-
Suster S., Moran C.A. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases. Am J Surg Pathol 1996, 20:1469-1480.
-
(1996)
Am J Surg Pathol
, vol.20
, pp. 1469-1480
-
-
Suster, S.1
Moran, C.A.2
-
14
-
-
0029957181
-
Real time quantitative PCR
-
Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res 1996, 6:986-994.
-
(1996)
Genome Res
, vol.6
, pp. 986-994
-
-
Heid, C.A.1
Stevens, J.2
Livak, K.J.3
Williams, P.M.4
-
15
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method
-
Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
-
(2001)
Methods
, vol.25
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
16
-
-
79954550873
-
Molecular predictors of response to chemotherapy in non-small cell lung cancer
-
Andrews J., Yeh P., Pao W., Horn L. Molecular predictors of response to chemotherapy in non-small cell lung cancer. Cancer J 2011, 17:104-113.
-
(2011)
Cancer J
, vol.17
, pp. 104-113
-
-
Andrews, J.1
Yeh, P.2
Pao, W.3
Horn, L.4
-
17
-
-
73349084270
-
Differential thymidylate synthase expression in different variants of large-cell carcinoma of the lung
-
Monica V., Scagliotti G.V., Ceppi P., Righi L., Cambieri A., Lo Iacono M., et al. Differential thymidylate synthase expression in different variants of large-cell carcinoma of the lung. Clin Cancer Res 2009, 15:7547-7552.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 7547-7552
-
-
Monica, V.1
Scagliotti, G.V.2
Ceppi, P.3
Righi, L.4
Cambieri, A.5
Lo Iacono, M.6
-
18
-
-
80755130096
-
Expression of thymidylate synthase, orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in thymic epithelial tumors
-
Kaira K., Serizawa M., Koh Y., Miura S., Kaira R., Abe M., et al. Expression of thymidylate synthase, orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in thymic epithelial tumors. Lung Cancer 2011, 74:419-425.
-
(2011)
Lung Cancer
, vol.74
, pp. 419-425
-
-
Kaira, K.1
Serizawa, M.2
Koh, Y.3
Miura, S.4
Kaira, R.5
Abe, M.6
-
19
-
-
79958178777
-
East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians
-
Zhou W., Christiani D.C. East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians. Chin J Cancer 2011, 30:287-292.
-
(2011)
Chin J Cancer
, vol.30
, pp. 287-292
-
-
Zhou, W.1
Christiani, D.C.2
-
20
-
-
39749121476
-
Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors
-
Ceppi P., Volante M., Ferrero A., Righi L., Rapa I., Rosas R., et al. Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors. Clin Cancer Res 2008, 15:1059-1064.
-
(2008)
Clin Cancer Res
, vol.15
, pp. 1059-1064
-
-
Ceppi, P.1
Volante, M.2
Ferrero, A.3
Righi, L.4
Rapa, I.5
Rosas, R.6
-
21
-
-
14644415548
-
Evaluation of TS-1 based treatment and expression of thymidylate synthase and dihydropyrimidine dehydrogenase on oral squamous cell carcinoma
-
Obara S., Yamamoto K., Hosogai N., Yoshimura Y. Evaluation of TS-1 based treatment and expression of thymidylate synthase and dihydropyrimidine dehydrogenase on oral squamous cell carcinoma. Oral Oncol 2005, 41:276-282.
-
(2005)
Oral Oncol
, vol.41
, pp. 276-282
-
-
Obara, S.1
Yamamoto, K.2
Hosogai, N.3
Yoshimura, Y.4
-
22
-
-
31544471397
-
Intratumoural expression of thymidylate synthase is an independent predictor of prognosis in patients with squamous cell carcinoma of the tongue: results from a retrospective study
-
Kawano K., Yanagisawa S., Kusukawa J., Sunagawa H., Shiba R., Goto M., et al. Intratumoural expression of thymidylate synthase is an independent predictor of prognosis in patients with squamous cell carcinoma of the tongue: results from a retrospective study. Int J Oral Maxillofac Surg 2006, 35:258-264.
-
(2006)
Int J Oral Maxillofac Surg
, vol.35
, pp. 258-264
-
-
Kawano, K.1
Yanagisawa, S.2
Kusukawa, J.3
Sunagawa, H.4
Shiba, R.5
Goto, M.6
-
23
-
-
77951009287
-
Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancer
-
Chiappori A.A., Zheng Z., Chen T., Rawal B., Schell M.J., Mullaney B.P., et al. Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancer. J Thorac Oncol 2010, 5:484-490.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 484-490
-
-
Chiappori, A.A.1
Zheng, Z.2
Chen, T.3
Rawal, B.4
Schell, M.J.5
Mullaney, B.P.6
-
24
-
-
84867250442
-
Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma
-
Kaira K., Ohde Y., Nakagawa K., Okumura T., Murakami H., Takahashi T., et al. Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma. Med Oncol 2012, 29:1663-1672.
-
(2012)
Med Oncol
, vol.29
, pp. 1663-1672
-
-
Kaira, K.1
Ohde, Y.2
Nakagawa, K.3
Okumura, T.4
Murakami, H.5
Takahashi, T.6
-
25
-
-
67650456927
-
Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition
-
Racanelli A.C., Rothbart S.B., Heyer C.L., Moran R.G. Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition. Cancer Res 2009, 69:5467-5474.
-
(2009)
Cancer Res
, vol.69
, pp. 5467-5474
-
-
Racanelli, A.C.1
Rothbart, S.B.2
Heyer, C.L.3
Moran, R.G.4
-
26
-
-
84857789861
-
Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma
-
Hirashima K., Baba Y., Watanabe M., Karashima R.I., Sato N., Imamura Y., et al. Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma. Br J Cancer 2012, 106:876-882.
-
(2012)
Br J Cancer
, vol.106
, pp. 876-882
-
-
Hirashima, K.1
Baba, Y.2
Watanabe, M.3
Karashima, R.I.4
Sato, N.5
Imamura, Y.6
-
27
-
-
37749051218
-
Rapamycin enhances the anti-tumor effect of gemcitabine in pancreatic cancer cells
-
Okada T., Sawada T., Kubota K. Rapamycin enhances the anti-tumor effect of gemcitabine in pancreatic cancer cells. Hepatogastroenterology 2007, 54:2129-2133.
-
(2007)
Hepatogastroenterology
, vol.54
, pp. 2129-2133
-
-
Okada, T.1
Sawada, T.2
Kubota, K.3
-
28
-
-
33645690146
-
In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer
-
Ito D., Fujimoto K., Mori T., Kami K., Koizumi M., Toyoda E., et al. In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer. Int J Cancer 2006, 118:2337-2343.
-
(2006)
Int J Cancer
, vol.118
, pp. 2337-2343
-
-
Ito, D.1
Fujimoto, K.2
Mori, T.3
Kami, K.4
Koizumi, M.5
Toyoda, E.6
|